Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vtv Theraptcs Cl A (VTVT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,838
  • Shares Outstanding, K 40,746
  • Annual Sales, $ 290 K
  • Annual Income, $ -16,140 K
  • 36-Month Beta -3.68
  • Price/Sales 3.04
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.30 +3.04%
on 02/15/19
3.40 -30.29%
on 01/24/19
-0.12 (-4.82%)
since 01/15/19
3-Month
1.00 +137.00%
on 12/27/18
3.50 -32.29%
on 12/28/18
+0.46 (+24.08%)
since 11/15/18
52-Week
0.65 +264.62%
on 04/11/18
7.26 -67.36%
on 02/20/18
-4.00 (-62.79%)
since 02/15/18

Most Recent Stories

More News
Watch These 4 Healthcare Stocks Set the Pace on Friday (1/25/19)

CORAL GABLES, FL / ACCESSWIRE / January 25, 2019 / The market has become increasingly more exciting over the last few months, with headlines detailing inventive treatments and strategic acquisitions popping...

RWLK : 0.32 (+6.31%)
VTVT : 2.37 (-3.27%)
WEED.TO : 62.81 (+2.50%)
PHGI.CN : 0.830 (unch)
PHGRF : 0.6316 (+1.95%)
CGC : 47.56 (+3.12%)
vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study

vTv Therapeutics Inc. (Nasdaq: VTVT) today announced the publication of a paper in Science Translational Medicine showcasing the discovery and development of TTP399, an investigational,...

VTVT : 2.37 (-3.27%)
Biotech Rally Ahead of the Market

HENDERSON, NV / ACCESSWIRE / January 2, 2019 / Biotech hit its bear market phase weeks before the market as a whole did. Some analysts think this means the turnaround will come sooner. Here's a few biotech...

VTVT : 2.37 (-3.27%)
ENDV : 0.0234 (+5.41%)
GILD : 67.59 (+1.84%)
PTLA : 30.96 (+3.86%)
Thinking about buying stock in Aurinia Pharmaceuticals Inc, Eagle Bancorp, Canada Goose Holdings Inc., New Age Beverages Corp, or vTv Therapeutics Inc.?

InvestorsObserver issues critical PriceWatch Alerts for AUPH, EBMT, GOOS, NBEV, and VTVT.

NBEV : 6.52 (-1.21%)
AUPH : 6.61 (+0.61%)
EBMT : 17.50 (+0.29%)
VTVT : 2.37 (-3.27%)
GOOS : 50.11 (-2.76%)
Biotech Companies in the News

HENDERSON, NV / ACCESSWIRE / December 31, 2018 / Several biotech companies have released major announcements this holiday season setting themselves up for a strong start to 2019.

VTVT : 2.37 (-3.27%)
ENDV : 0.0234 (+5.41%)
OPK : 2.86 (+2.51%)
4 Healthcare Stocks Gaining Speed on Friday (12/28/18)

CORAL GABLES, FL / ACCESSWIRE / December 28,2018 / With the new year only a few short days away, the is stirring withexcitement surrounding announcements of innovative treatment options and nuanced approaches...

TDOC : 69.43 (+4.28%)
VTVT : 2.37 (-3.27%)
PHGI.CN : 0.830 (unch)
PHGRF : 0.6316 (+1.95%)
OPK : 2.86 (+2.51%)
Detailed Research: Economic Perspectives on Honeywell International, Tabula Rasa Healthcare, El Pollo Loco, Acceleron Pharma, vTv Therapeutics, and 22nd Century Group -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Honeywell International Inc....

VTVT : 2.37 (-3.27%)
HON : 153.32 (+1.86%)
XLRN : 42.46 (+1.65%)
XXII : 2.55 (+1.19%)
LOCO : 15.21 (+3.54%)
TRHC : 57.97 (+5.15%)
vTv Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference

vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company management will present a corporate overview at the Piper Jaffray 30th Annual Healthcare Conference on Tuesday, Nov. 27,...

VTVT : 2.37 (-3.27%)
VTv Therapeutics (VTVT) Reports Q3 Loss, Tops Revenue Estimates

vTv Therapeutics (VTVT) delivered earnings and revenue surprises of 60.00% and 63.84%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

VTVT : 2.37 (-3.27%)
vTv Therapeutics Announces Third Quarter 2018 Results and Update

vTv Therapeutics Inc. (Nasdaq: VTVT) today reported financial results for the third quarter that ended September 30, 2018, and provided an update on recent achievements and upcoming...

VTVT : 2.37 (-3.27%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More Share

Trade VTVT with:

Business Summary

vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical...

See More

Key Turning Points

2nd Resistance Point 2.59
1st Resistance Point 2.48
Last Price 2.37
1st Support Level 2.28
2nd Support Level 2.19

See More

52-Week High 7.26
Fibonacci 61.8% 4.73
Fibonacci 50% 3.96
Fibonacci 38.2% 3.18
Last Price 2.37
52-Week Low 0.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar